Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Tyrosine kinase inhibitors are important in the treatment of metastatic renal cell cancer (mRCC). The aim of the study was to evaluate the costs and effects of sunitinib in mRCC.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Anticancer Res

Title: Anticancer research

Publisher: Anticancer Research USA Inc.

ISSN (Electronic): 1791-7530

ISSN (Print): 0250-7005

Publication date (Electronic): Oct 2019

Volume: 39

Issue: 10

Affiliations

[1 ] Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland Riikka-Liisa.Vuorinen@tuni.fi.

[2 ] Department of Gynecology and Obstetrics, Tampere University Hospital, Tampere, Finland.

[3 ] Department of Oncology, Tampere University Hospital, Tampere, Finland.

[4 ] Department of Oncology, Medical Research Center, Oulu University Hospital, Cancer and Translational Research Unit, Oulu University, Oulu, Finland.

[5 ] Department of Oncology, Turku University Hospital, Turku, Finland.

[6 ] Department of Oncology, Vaasa Central Hospital, Turku University, Vaasa, Finland.

[7 ] Department of Oncology, Kuopio University Hospital and Central Finland Central Hospital, Kuopio, Finland.

[8 ] Department of Public Health, University of Helsinki, Helsinki, Finland.

[9 ] Oy Medfiles Ltd, Kuopio, Finland.

[10 ] Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere University Hospital, Tampere, Finland.

Article

Publisher Item ID: 39/10/5559

DOI: 10.21873/anticanres.13749

PubMed ID: 31570450

SO-VID: 537369bb-cacb-471a-856d-dca4b2f6f219

History

Keywords: RCC,costs,mRCC,metastatic,sunitinib

Data availability:

Keywords: RCC, costs, mRCC, metastatic, sunitinib

Comments

Comment on this article

scite_

Cited by 1

Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory Mediators
Authors: Tsutomu Yuno, Yasuyoshi Miyata, Yuta Mukae …

See all cited by